The acquired immunodeficiency syndrome in infants and children

Insights

Diagnosing pediatric acquired immunodeficiency syndrome (AIDS) involves assessing risk factors, distinct immune system changes like hypergammaglobulinemia, and confirming the AIDS retrovirus. Early infant diagnosis requires viral isolation to rule out passive antibody transfer.

Area of Science:

  • Pediatrics
  • Immunology
  • Virology

Background:

  • Pediatric acquired immunodeficiency syndrome (AIDS) presents unique diagnostic challenges.
  • Risk factors include maternal intravenous drug use, contaminated blood transfusions, and factor VIII therapy.
  • A specific immunologic profile, including polyclonal hypergammaglobulinemia and T-cell immunodeficiency, is characteristic of pediatric AIDS.

Purpose of the Study:

  • To outline the diagnostic criteria for pediatric acquired immunodeficiency syndrome (AIDS).
  • To differentiate pediatric AIDS from other immunodeficiency disorders.
  • To emphasize the importance of virologic confirmation in diagnosis.

Main Methods:

  • Classification based on epidemiologic, immunologic, and virologic data.
  • Identification of individuals at risk for pediatric AIDS.
  • Exclusion of primary immunodeficiency diseases such as adenosine deaminase and purine nucleoside phosphorylase deficiency.

Main Results:

  • Pediatric AIDS is characterized by a distinct immunologic phenotype: polyclonal hypergammaglobulinemia and T-cell immunodeficiency.
  • Detection of antibody to the AIDS retrovirus or viral isolation is crucial for diagnosis.
  • In early infancy, viral isolation is essential to overcome passive IgG transfer from the mother.

Conclusions:

  • A diagnosis of pediatric AIDS is established by the presence of risk factors, characteristic immunologic abnormalities, and confirmation of the AIDS retrovirus.
  • Distinguishing pediatric AIDS from other immunodeficiencies is critical for appropriate management.
  • Virologic confirmation is paramount, especially in infants, to ensure accurate diagnosis.

Related Concept Videos

Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...